Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
29.27
+0.87 (+3.06%)
Streaming Delayed Price
Updated: 2:36 PM EDT, May 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
32
33
Next >
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
↗
April 15, 2024
Via
Benzinga
Viking Therapeutics: Strong Results In Obesity
↗
April 13, 2024
With a potential best in class drug for oral and injectable use, Viking Therapeutics has to be on many Big Pharma/Bio acquisition wish lists, as the company represents a very scarce asset in the $100...
Via
Talk Markets
3 Magnificent Stocks That Could Double or More by 2030
↗
April 13, 2024
There's no guarantee these stocks will double by 2030, but their growth prospects look great.
Via
The Motley Fool
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
↗
April 12, 2024
For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now.
Via
InvestorPlace
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
↗
April 11, 2024
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments.
Via
InvestorPlace
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
↗
April 09, 2024
Via
Benzinga
Is it Too Late to Buy Viking Therapeutics Stock?
↗
April 06, 2024
Viking Therapeutics stock is on fire following a successful phase 2 trial for its obesity care candidate.
Via
The Motley Fool
Viking Therapeutics Just Announced More Positive Results: Time to Buy?
↗
April 04, 2024
The drugmaker isn't losing momentum.
Via
The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today
↗
April 02, 2024
Via
Benzinga
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
↗
April 09, 2024
These rising drugmakers have serious arguments in their favor.
Via
The Motley Fool
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.
↗
April 09, 2024
Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate.
Via
The Motley Fool
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
April 09, 2024
Altimmune has a GLP-1 candidate in Phase 2 trials, but the company continues to burn cash and may need a big pharma partner to get its drug to market
Via
MarketBeat
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
↗
April 08, 2024
Shares of the clinical-stage biotech have skyrocketed on recent good news.
Via
The Motley Fool
MarketBeat Week in Review – 4/1 - 4/5
April 06, 2024
Equities lost ground this week as investors consider the effect of fewer rate cuts, rising oil prices, and robust job gains ahead of a new earnings season
Via
MarketBeat
Topics
Economy
Looking Into Viking Therapeutics's Recent Short Interest
↗
April 01, 2024
Via
Benzinga
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
↗
April 05, 2024
These businesses should see good times ahead.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
April 04, 2024
Via
Benzinga
1 Brand-New (Good) Reason to Buy Viking Therapeutics Stock Now
↗
April 04, 2024
Its long-term growth potential looks like it's improving, again.
Via
The Motley Fool
2 Potentially Explosive Stocks to Buy in April
↗
April 04, 2024
These two healthcare stocks should have plenty of room to run.
Via
The Motley Fool
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
↗
April 04, 2024
Viking shares have soared recently on optimism about its program.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
April 03, 2024
Via
Benzinga
Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
April 03, 2024
Viking Therapeutics is preparing to be the next entry into the GLP-1 Market, and VKTX stock is soaring as analysts start to bid the stock higher
Via
MarketBeat
5 Healthcare Stocks to Buy for 2024
↗
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
↗
April 02, 2024
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets.
Via
InvestorPlace
Tuesday Talk: April Is The Cruelest Month?
↗
April 02, 2024
At least that is what the poet T.S. Eliot wrote in the opening line of his well-known poem,
Via
Talk Markets
Could Viking Therapeutics Stock Be a Millionaire Maker?
↗
April 02, 2024
There is a plausible path for this biotech stock to make some investors millionaires.
Via
The Motley Fool
Russell 2000 Index Best And Worst Performing Stocks Of 2024
↗
April 02, 2024
The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024.
Via
Talk Markets
Topics
Stocks
The 3 Best Biotech Stocks to Buy in April 2024
↗
April 01, 2024
Biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April.
Via
InvestorPlace
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
↗
April 01, 2024
The company's experimental new weight-management drug looks great so far.
Via
The Motley Fool
2 Top Biotech Buyout Candidates
↗
March 31, 2024
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...
Via
Talk Markets
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
